Did You Know?

Editor’s Picks

Latest News

Elevar Therapeutics Resubmits New Drug Application to FDA for Combination of Camrelizumab plus Rivoceranib for Use as a First-line Treatment Option for Unresectable or Metastatic Hepatocellular Carcinoma

New York City Biotech Startups Neion Bio and Barnwell Bio Partner to Advance Biomanufacturing and Biosecurity

The collaboration brings together Neion Bio's egg-based biologics manufacturing platform and Barnwell Bio's metagenomic biosurveillance capabilities, while highlighting the growing...

Baylor Genetics Study Finds Genome Sequencing Identifies Genetic Diagnoses in Nearly One-Third of Children with Intellectual Disability and Developmental Delay

HOUSTON, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of comprehensive...

UPDATE – MindBio Completes Manufacture of Next-Generation Voice AI Intoxication Detection Kiosk. Advances Software Validation & Testing In Preparation for First Commercial Pilot.

VANCOUVER, British Columbia, Oct. 14, 2026 (GLOBE NEWSWIRE) -- MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) (the “Company”...

MindBio Completes Manufacture of Next-Generation Voice AI Intoxication Detection Kiosk. Advances Software Validation & Testing Towards In Preparation for First Commercial Pilot.

VANCOUVER, British Columbia, Oct. 14, 2026 (GLOBE NEWSWIRE) -- MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) (the “Company”...

Editas Medicine Announces Poster Presentations at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress and Participation in Upcoming Investor Conference

CAMBRIDGE, Mass., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on...

Parexel to Spotlight Site Partnership, Innovation & Industry-Leading Site Performance at 2026 Society for Clinical Research Sites (SCRS) Global Site Solutions Summit™

Company brings its expertise in driving faster site activation and enrollment and better patient retention to panel discussions; continues commitment...

error: Content is protected !!